Discussion Paper. On Friday June 24, the PMPRB released a long delayed discussion paper covering a wide range of issues ... Read More
News
27
Jun2016
20
Jun2016
In February 2015, PDCI Market Access (PDCI) released a report entitled pCPA Negotiation Guidelines. That report, which was a ... Read More
03
Jun2016
The British Columbia PharmaCare (BC PharmaCare) is modernizing the Reference Drug Program (RDP). Effective immediately, transitional coverage is in place ... Read More
01
Jun2016
The Régie de l’assurance maladie du Québec (RAMQ) is scheduled to release its June update of the List of Medications ... Read More
26
May2016
Effective immediately, CADTH will be formally engaging with the pan-Canadian Pharmaceutical Alliance (pCPA) and will be including the pCPA office ... Read More
25
May2016
Effective June 1, 2016, the Nova Scotia Pharmacare will begin funding INFLECTRA™ (infliximab) as an exception status benefit. For infliximab-naïve ... Read More
18
May2016
The pan-Canadian Pharmaceutical Alliance (pCPA): Negotiations Status Update
/ News, pCPA, What's New
The pan-Canadian Pharmaceutical Alliance (pCPA) updated the status of negotiations on brand name drugs as of April 30, 2016:
23 ... Read More
17
May2016
CADTH Releases Recommendations Report for Anti-Vascular Endothelial Growth Factor Drugs for Retinal Conditions
/ CADTH, News, What's New
On May 5, 2016, the Canadian Agency for Drugs and Technologies in Health (CADTH) released a Recommendations Report on its ... Read More